The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | V | Various | |
2 | V09 | Diagnostic radiopharmaceuticals | |
3 | V09I | Tumour detection | |
4 | V09IX | Other diagnostic radiopharmaceuticals for tumour detection | |
5 | V09IX18 |
Active Ingredient | Description | |
---|---|---|
Flotufolastat ¹⁸F |
Flotufolastat (18F) is a radioactive diagnostic agent for intravenous use. Flotufolastat (18F) binds to PSMA (IC50 = 4.4 nM) expressed on cells, including prostate cancer cells, and is internalized. Prostate cancer cells usually overexpress PSMA. Fluorine-18 is a β+ emitting radionuclide that can be detected using positron emission tomography. |